MIR17HG and non-small cell lung carcinoma: In conclusion, MIR17HG was downregulated in NSCLC and may upregulate miR-142-3p through methylation pathway to promote its expression, thereby downregulating Bach-1 and suppress cancer cell invasion and migration.